Article Listing - GSK boss defends OTC business

YUGOSLAV VACCINE PROGRAM

13 April 1992

ICN Pharmaceuticals of California and ICN-Galenika are to partly finance a project costing over $100,000 to vaccinate children in the...

COPROMOTION OF SPARFLOXACIN

13 April 1992

Warner-Lambert and Rhone-Poulenc Rorer have agreed that the latter will codevelop and copromote the orally-active quinolone antibiotic sparfloxacin in the...

SCHERING CORP TO MARKET FELBAMATE

13 April 1992

Schering Corp reports that it will have exclusive rights to market Carter-Wallace's N-methyl-D-aspartate receptor antagonist anticonvulsant felbamate worldwide, with the...

URIACH BUILDS NEW PLANT

13 April 1992

The Spanish pharmaceutical comp-any, Uriach, is constructing a new plant, reports the Spanish magazine Siete Dias Medicos.

The work is...

ROCHE'S LOCERYL LAUNCHED IN FRANCE

13 April 1992

Roche Produits, a subsidiary of Hoffmann-La Roche, has introduced its nail lacquer antifungal product Loceryl (amorolfine). This is the first...

INTERNATIONAL INDUSTRY DISCUSSES JAPAN

13 April 1992

Representatives of the Japan Pharmaceutical Manufacturers Association, the European Busi-ness Council and the US Pharmaceutical Manufacturers Association met in Palm...

EARLY FIGURES SHOW GOOD UK PHARMA TRADE BALANCE

13 April 1992

For January of this year, the UK pharmaceutical industry reported a massive 66% increase in trade with the rest of...

CANGUARD CLEARED OF CONTEMPT

13 April 1992

The Canadian company Canguard Health Technologies has been cleared of contempt of court charges brought by Deprenyl Research Ltd regarding...

NEW GENERAL COUNSEL AT IDEC

13 April 1992

At IDEC Pharmaceuticals Corp, Kenneth Woolcott has been promoted to general counsel.

ROCHE CONSOLIDATED PROFIT LEAPS 56% IN 1991

13 April 1992

For 1991, Swiss pharmaceutical major Hoffmann-La Roche reported "continued and significant improvement in the group's earning performance," with consolidated group...